Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients

  • Stefano Nicolè
  • , Massimiliano Lanzafame
  • , Emanuela Lattuada
  • , Dora Luise
  • , Marta Vecchi
  • , Evelina Tacconelli
  • , Sandro Vento

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients'. Together they form a unique fingerprint.